Interestingly, the functional coupling of SLC1A5 and SLC7A5 glutamine transporters suggests that enhanced glutamine metabolism in tumor cells can contribute to drive tumor growth through activation of mTOR [68]. The gene discussed is SLC1A5; the disease is neoplasm.